CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...